{"count": 6, "results": [{"_id": "33644093", "pmid": 33644093, "pmcid": "PMC7904887", "title": "Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment", "journal": "Front Med (Lausanne)", "authors": ["Leutner M", "Matzhold C", "Kautzky A", "Kaleta M", "Thurner S", "Klimek P", "Kautzky-Willer A"], "date": "2021-02-11T00:00:00Z", "doi": "10.3389/fmed.2021.608083", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "608083", "score": 50266.73, "text_hl": "However, there was a dose dependent relationship between statins and diagnosis of @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@MDD@@@. Compared to controls, the ORs of @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@MDD@@@ were lower for low-dose statin-treated @SPECIES_9606 @@@patients@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@>0- < =10 mg:OR: 0.59, 95% CI: 0.54-0.64; @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@>0- < =10 mg:OR:0.65, 95%CI: 0.59-0.70; @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@>0- < =10 mg:OR: 0.68, 95% CI: 0.53-0.85). ", "citations": {"NLM": "Leutner M, Matzhold C, Kautzky A, Kaleta M, Thurner S, Klimek P, Kautzky-Willer A. Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment Front Med (Lausanne). 2021;8():608083. PMID: 33644093", "BibTeX": "@article{33644093, title={Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment}, author={Leutner M and Matzhold C and Kautzky A and Kaleta M and Thurner S and Klimek P and Kautzky-Willer A}, journal={Front Med (Lausanne)}, volume={8}, pages={608083}}"}}, {"_id": "34947895", "pmid": 34947895, "pmcid": "PMC8703562", "title": "Update on Statin Treatment in Patients with Neuropsychiatric Disorders", "journal": "Life (Basel)", "authors": ["Avan R", "Sahebnasagh A", "Hashemi J", "Monajati M", "Faramarzi F", "Henney NC", "Montecucco F", "Jamialahmadi T", "Sahebkar A"], "date": "2021-12-08T00:00:00Z", "doi": "10.3390/life11121365", "meta_date_publication": "2021 Dec 8", "meta_volume": "11", "meta_issue": "12", "meta_pages": "", "score": 50263.15, "text_hl": "Of the participants who received lipophilic statins, only @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was associated with a moderate increase in the risk of @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@MDD@@@. ", "citations": {"NLM": "Avan R, Sahebnasagh A, Hashemi J, Monajati M, Faramarzi F, Henney NC, Montecucco F, Jamialahmadi T, Sahebkar A. Update on Statin Treatment in Patients with Neuropsychiatric Disorders Life (Basel). 2021 Dec 8;11(12):. PMID: 34947895", "BibTeX": "@article{34947895, title={Update on Statin Treatment in Patients with Neuropsychiatric Disorders}, author={Avan R and Sahebnasagh A and Hashemi J and Monajati M and Faramarzi F and Henney NC and Montecucco F and Jamialahmadi T and Sahebkar A}, journal={Life (Basel)}, volume={11}, number={12}}"}}, {"_id": "33262189", "pmid": 33262189, "pmcid": "PMC7709515", "title": "Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial", "journal": "BMJ Open", "authors": ["Otte C", "Chae WR", "Nowacki J", "Kaczmarczyk M", "Piber D", "Roepke S", "Märschenz S", "Lischewski S", "Schmidt S", "Ettrich B", "Grabe HJ", "Hegerl U", "Hinkelmann K", "Hofmann T", "Janowitz D", "Junghanns K", "Kahl KG", "Klein JP", "Krueger THC", "Leicht G", "Prvulovic D", "Reif A", "Schoettle D", "Strauss M", "Westermair A", "Friede T", "Gold SM"], "date": "2020-12-01T00:00:00Z", "doi": "10.1136/bmjopen-2020-040119", "meta_date_publication": "2020 Dec 1", "meta_volume": "10", "meta_issue": "12", "meta_pages": "e040119", "score": 50254.22, "text_hl": "This is a confirmative randomised controlled trial to examine the antidepressive potential of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ as add-on therapy in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@major depressive disorder@@@ (@<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@MDD@@@) and comorbid @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@.", "citations": {"NLM": "Otte C, Chae WR, Nowacki J, Kaczmarczyk M, Piber D, Roepke S, Märschenz S, Lischewski S, Schmidt S, Ettrich B, Grabe HJ, Hegerl U, Hinkelmann K, Hofmann T, Janowitz D, Junghanns K, Kahl KG, Klein JP, Krueger THC, Leicht G, Prvulovic D, Reif A, Schoettle D, Strauss M, Westermair A, Friede T, Gold SM. Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial BMJ Open. 2020 Dec 1;10(12):e040119. PMID: 33262189", "BibTeX": "@article{33262189, title={Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trial}, author={Otte C and Chae WR and Nowacki J and Kaczmarczyk M and Piber D and Roepke S and Märschenz S and Lischewski S and Schmidt S and Ettrich B and Grabe HJ and Hegerl U and Hinkelmann K and Hofmann T and Janowitz D and Junghanns K and Kahl KG and Klein JP and Krueger THC and Leicht G and Prvulovic D and Reif A and Schoettle D and Strauss M and Westermair A and Friede T and Gold SM}, journal={BMJ Open}, volume={10}, number={12}, pages={e040119}}"}}, {"_id": "36915729", "pmid": 36915729, "title": "A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction.", "journal": "Am J Transl Res", "authors": ["Yu C", "Zhang F", "Zhang L", "Li J", "Tang S", "Li X", "Peng M", "Zhao Q", "Zhu X"], "date": "2023-02-15T00:00:00Z", "meta_date_publication": "2023", "meta_volume": "15", "meta_issue": "2", "meta_pages": "932-948", "score": 50248.28, "text_hl": "This study investigated the pathogenesis of @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@major depressive disorder@@@ (@<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@MDD@@@) and @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@ (@DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@AMI@@@) using bioinformatics. ", "citations": {"NLM": "Yu C, Zhang F, Zhang L, Li J, Tang S, Li X, Peng M, Zhao Q, Zhu X. A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction. Am J Transl Res. 2023;15(2):932-948. PMID: 36915729", "BibTeX": "@article{36915729, title={A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction.}, author={Yu C and Zhang F and Zhang L and Li J and Tang S and Li X and Peng M and Zhao Q and Zhu X}, journal={Am J Transl Res}, volume={15}, number={2}, pages={932-948}}"}}, {"_id": "25827645", "pmid": 25827645, "title": "Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.", "journal": "J Psychopharmacol", "authors": ["Gougol A", "Zareh-Mohammadi N", "Raheb S", "Farokhnia M", "Salimi S", "Iranpour N", "Yekehtaz H", "Akhondzadeh S"], "date": "2015-05-01T00:00:00Z", "doi": "10.1177/0269881115578160", "meta_date_publication": "2015 May", "meta_volume": "29", "meta_issue": "5", "meta_pages": "575-81", "score": 50059.383, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ as an adjuvant therapy to @CHEMICAL_Fluoxetine @CHEMICAL_MESH:D005473 @@@fluoxetine@@@ in @SPECIES_9606 @@@patients@@@ with moderate to severe @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@major depression@@@: A double-blind placebo-controlled trial.", "citations": {"NLM": "Gougol A, Zareh-Mohammadi N, Raheb S, Farokhnia M, Salimi S, Iranpour N, Yekehtaz H, Akhondzadeh S. Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial. J Psychopharmacol. 2015 May;29(5):575-81. PMID: 25827645", "BibTeX": "@article{25827645, title={Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.}, author={Gougol A and Zareh-Mohammadi N and Raheb S and Farokhnia M and Salimi S and Iranpour N and Yekehtaz H and Akhondzadeh S}, journal={J Psychopharmacol}, volume={29}, number={5}, pages={575-81}}"}}, {"_id": "30762508", "pmid": 30762508, "pmcid": "PMC6381416", "title": "Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial", "journal": "BJPsych Open", "authors": ["Husain MI", "Chaudhry IB", "Khoso AB", "Husain MO", "Rahman RR", "Hamirani MM", "Hodsoll J", "Carvalho AF", "Husain N", "Young AH"], "date": "2019-01-01T00:00:00Z", "doi": "10.1192/bjo.2018.84", "meta_date_publication": "2019 Jan", "meta_volume": "5", "meta_issue": "1", "meta_pages": "e13", "score": 50055.223, "text_hl": "To report on a protocol for a 12-week, randomised, double-blind, placebo-controlled trial of add-on treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for @SPECIES_9606 @@@patients@@@ meeting DSM@DISEASE_Lymphoproliferative_Disorders @DISEASE_MESH:D008232 @@@-5@@@ criteria for @<m>DISEASE_Depressive_Disorder_Major</m> @DISEASE_MESH:D003865 @@@MDD@@@ who have failed to respond to at least two adequate trials with approved antidepressants. ", "citations": {"NLM": "Husain MI, Chaudhry IB, Khoso AB, Husain MO, Rahman RR, Hamirani MM, Hodsoll J, Carvalho AF, Husain N, Young AH. Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial BJPsych Open. 2019 Jan;5(1):e13. PMID: 30762508", "BibTeX": "@article{30762508, title={Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial}, author={Husain MI and Chaudhry IB and Khoso AB and Husain MO and Rahman RR and Hamirani MM and Hodsoll J and Carvalho AF and Husain N and Young AH}, journal={BJPsych Open}, volume={5}, number={1}, pages={e13}}"}}]}